Lyngby, Denmark

Lauge Schaeffer

USPTO Granted Patents = 14 

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 2013-2021

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Lauge Schaeffer: Innovator in Diabetes and Obesity Treatment

Introduction

Lauge Schaeffer is a prominent inventor based in Lyngby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for diabetes, obesity, and cardiovascular diseases. With a total of 14 patents to his name, Schaeffer's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents is the invention of acylated insulin analogues and their uses. This invention relates to novel insulin analogues and derivatives, which are crucial for the treatment or prevention of medical conditions associated with diabetes, obesity, and cardiovascular diseases. Another notable patent is for an amylin and calcitonin receptor agonist. This invention involves peptides comprising a specific amino acid sequence and their pharmaceutical compositions, which are intended for use as medicaments.

Career Highlights

Lauge Schaeffer has built a successful career at Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk has allowed him to focus on innovative solutions for chronic conditions, particularly those affecting metabolic health. His contributions have been instrumental in advancing the company's research and development efforts.

Collaborations

Throughout his career, Schaeffer has collaborated with notable colleagues, including Thomas Kruse and Henning Thoegersen. These collaborations have fostered a productive environment for innovation and have led to the development of groundbreaking medical treatments.

Conclusion

Lauge Schaeffer's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and contributions continue to pave the way for advancements in the treatment of diabetes and related health issues. His dedication to improving patient outcomes through scientific research is commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…